Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 91 - 100 of 319 items for :

  • "incidence" x
Clear All
Rachelle P Mendoza Department of Pathology, University of Rochester Medical Center, Rochester, New York, USA

Search for other papers by Rachelle P Mendoza in
Google Scholar
PubMed Close
,
Richard Cody Simon Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Richard Cody Simon in
Google Scholar
PubMed Close
,
Nicole A Cipriani Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Nicole A Cipriani in
Google Scholar
PubMed Close
, and
Tatjana Antic Department of Pathology, University of Chicago, Chicago, Illinois, USA

Search for other papers by Tatjana Antic in
Google Scholar
PubMed Close

-up information of these nodules. The incidence rate of a nonbenign final diagnosis in these nodules with single FNA was 0% ( Table 2 ). Figure 1 Diagram of the subsequent fine needle aspiration cytology and resection diagnosis of benign thyroid nodules

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-23-0153
Volume/Issue:
Volume 13: Issue 1
Open access
Ziyu Wan Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

Search for other papers by Ziyu Wan in
Google Scholar
PubMed Close
,
Ying Li Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Ying Li in
Google Scholar
PubMed Close
,
Xiaoqian Dong Xiangya School of Nursing, Central South University, Changsha, Hunan, China

Search for other papers by Xiaoqian Dong in
Google Scholar
PubMed Close
,
Yue Kang Xiangya School of Nursing, Central South University, Changsha, Hunan, China

Search for other papers by Yue Kang in
Google Scholar
PubMed Close
,
Juan Luo Xiangya School of Nursing, Central South University, Changsha, Hunan, China

Search for other papers by Juan Luo in
Google Scholar
PubMed Close
,
Jiangang Wang Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Jiangang Wang in
Google Scholar
PubMed Close
,
Pingting Yang Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Pingting Yang in
Google Scholar
PubMed Close
,
Yaqin Wang Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Yaqin Wang in
Google Scholar
PubMed Close
,
Yinglong Duan Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

Search for other papers by Yinglong Duan in
Google Scholar
PubMed Close
,
Jianfei Xie Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

Search for other papers by Jianfei Xie in
Google Scholar
PubMed Close
, and
Andy S K Cheng Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong, China

Search for other papers by Andy S K Cheng in
Google Scholar
PubMed Close

). However, the incidence of TNs is reported to be between 10.2% and 38.4% ( 2 , 3 , 4 , 5 ), and up to 7.9% of these nodules are malignant ( 6 ). Recent advancements in ultrasonographic techniques have enabled the early detection of TNs ( 7 ), thereby

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-23-0168
Volume/Issue:
Volume 12: Issue 6
Open access
George J. Kahaly Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, Mainz, Germany

Search for other papers by George J. Kahaly in
Google Scholar
PubMed Close
,
Luigi Bartalena Department of Medicine and Surgery, University of Insubria, Varese, Italy

Search for other papers by Luigi Bartalena in
Google Scholar
PubMed Close
,
Lazlo Hegedüs Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Lazlo Hegedüs in
Google Scholar
PubMed Close
,
Laurence Leenhardt Thyroid and Endocrine Tumors Unit, Pitié Salpêtrière Hospital, Sorbonne University, Paris, France

Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed Close
,
Kris Poppe Endocrine Unit, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium

Search for other papers by Kris Poppe in
Google Scholar
PubMed Close
, and
Simon H. Pearce Department of Endocrinology, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom

Search for other papers by Simon H. Pearce in
Google Scholar
PubMed Close

cases per 100,000 individuals [ 6 ]. GD occurs more often in women and has a population prevalence of 1–1.5%. Approximately 3% of women and 0.5% of men develop GD during their lifetime [ 7 ]. The peak incidence of GD occurs among patients aged 30

Article Type:
Guideline
DOI:
https://doi.org/10.1159/000490384
Volume/Issue:
Volume 7: Issue 4
Free access
Roberto Negro Division of Endocrinology, “V. Fazzi” Hospital, Lecce, Italy

Search for other papers by Roberto Negro in
Google Scholar
PubMed Close
and
Pierpaolo Trimboli Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland

Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed Close

uncertainties regarding nodule recurrence than certainties. Available data show a 5-year cumulative incidence of regrowth of 28%, and a 5-year cumulative incidence of retreatment of 10% [ 13 ]. On the one hand, we can state that TA is “cost- and risk

Article Type:
Editorial
DOI:
https://doi.org/10.1159/000509310
Volume/Issue:
Volume 9: Issue 4
Free access
Rosa M. García-Moreno Endocrinology and Nutrition Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Rosa M. García-Moreno in
Google Scholar
PubMed Close
,
Cristina Escabias Nuclear Medicine Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Cristina Escabias in
Google Scholar
PubMed Close
,
Cristina Utrilla Radiology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Cristina Utrilla in
Google Scholar
PubMed Close
,
Elena Ruiz-Bravo Pathology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Elena Ruiz-Bravo in
Google Scholar
PubMed Close
,
Margarita Sánchez Ophthalmology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Margarita Sánchez in
Google Scholar
PubMed Close
, and
Beatriz Lecumberri Endocrinology and Nutrition Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Beatriz Lecumberri in
Google Scholar
PubMed Close

incidental radioiodine uptake in the orbital region. Introduction Differentiated thyroid cancer is one of the most prevalent solid tumor types with a rising incidence, and papillary thyroid carcinoma (PTC) represents the most frequent variant [ 1

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000499911
Volume/Issue:
Volume 8: Issue 4
Free access
Alessandro Brancatella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed Close
,
Nicola Viola Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Nicola Viola in
Google Scholar
PubMed Close
,
Sandra Brogioni Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed Close
,
Lucia Montanelli Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Lucia Montanelli in
Google Scholar
PubMed Close
,
Chiara Sardella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Chiara Sardella in
Google Scholar
PubMed Close
,
Paolo Vitti Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed Close
,
Claudio Marcocci Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed Close
,
Isabella Lupi Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Isabella Lupi in
Google Scholar
PubMed Close
, and
Francesco Latrofa Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed Close

reported as a common adverse effect during ICPi treatment [ 1 ]. A similar overall incidence of hypothyroidism (7–10%) has been estimated for the three types of drugs. At variance, the incidence of thyrotoxicosis differs according to the ICPi regimen, being

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000501824
Volume/Issue:
Volume 8: Issue 4
Free access
Martina Tavarelli Unité Thyroïde Tumeurs Endocrines, Paris, France

Search for other papers by Martina Tavarelli in
Google Scholar
PubMed Close
,
Julie Sarfati Unité Thyroïde Tumeurs Endocrines, Paris, France

Search for other papers by Julie Sarfati in
Google Scholar
PubMed Close
,
Christian De Gennes Service de Médecine Interne Immuno-clinique, Paris, France

Search for other papers by Christian De Gennes in
Google Scholar
PubMed Close
,
Julien Haroche Service de Médecine Interne 2, Paris, France

Search for other papers by Julien Haroche in
Google Scholar
PubMed Close
,
Camille Buffet Unité Thyroïde Tumeurs Endocrines, Paris, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close
,
Cécile Ghander Unité Thyroïde Tumeurs Endocrines, Paris, France

Search for other papers by Cécile Ghander in
Google Scholar
PubMed Close
,
Jean Marc Simon Service de Radiothérapie, Paris, France

Search for other papers by Jean Marc Simon in
Google Scholar
PubMed Close
,
Fabrice Ménégaux Service de Chirurgie Générale et Digestive, Groupe Hospitalier et Faculté de Médecine Pitié-Salpêtrière, Institut du Cancer, Université Pierre et Marie Curie, Paris, France

Search for other papers by Fabrice Ménégaux in
Google Scholar
PubMed Close
, and
Laurence Leenhardt Unité Thyroïde Tumeurs Endocrines, Paris, France

Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed Close

, the incidence of paraneoplastic syndromes will most likely increase. Acknowledgments We thank L. Chami and V. Magnano San Lio for the help in the interpretation of radiological images. Disclosure Statement All authors declare they have

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000437052
Volume/Issue:
Volume 4: Issue 4
Free access
Peter Taylor Departments of Diabetes and Endocrinology, Royal United Hospital, Bath
Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK

Search for other papers by Peter Taylor in
Google Scholar
PubMed Close
,
Sandip Bhatt Departments of Gastroenterology, Royal United Hospital, Bath

Search for other papers by Sandip Bhatt in
Google Scholar
PubMed Close
,
Ravi Gouni Departments of Diabetes and Endocrinology, Royal United Hospital, Bath

Search for other papers by Ravi Gouni in
Google Scholar
PubMed Close
,
Jonathan Quinlan Departments of Gastroenterology, Royal United Hospital, Bath

Search for other papers by Jonathan Quinlan in
Google Scholar
PubMed Close
, and
Tony Robinson Departments of Diabetes and Endocrinology, Royal United Hospital, Bath

Search for other papers by Tony Robinson in
Google Scholar
PubMed Close

fetal loss [ 4 , 6 ]. • Anti-thyroid drugs are the mainstay of treatment throughout pregnancy [ 7 , 8 ]. • Propylthiouracil (PTU) is generally used first line in pregnancy following an increased incidence of scalp defects such as aplasia cutis [ 9

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000336071
Volume/Issue:
Volume 1: Issue 1
Free access
Ayanthi Wijewardene Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Ayanthi Wijewardene in
Google Scholar
PubMed Close
,
Matti Gild Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Matti Gild in
Google Scholar
PubMed Close
,
Carolina Nylén Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Carolina Nylén in
Google Scholar
PubMed Close
,
Geoffrey Schembri Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Geoffrey Schembri in
Google Scholar
PubMed Close
,
Paul Roach Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Paul Roach in
Google Scholar
PubMed Close
,
Jeremy Hoang Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Jeremy Hoang in
Google Scholar
PubMed Close
,
Ahmad Aniss Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Ahmad Aniss in
Google Scholar
PubMed Close
,
Anthony Glover Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Anthony Glover in
Google Scholar
PubMed Close
,
Mark Sywak Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Mark Sywak in
Google Scholar
PubMed Close
,
Stan Sidhu Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Stan Sidhu in
Google Scholar
PubMed Close
,
Diana Learoyd Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Diana Learoyd in
Google Scholar
PubMed Close
,
Bruce Robinson Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Bruce Robinson in
Google Scholar
PubMed Close
,
Lyndal Tacon Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Lyndal Tacon in
Google Scholar
PubMed Close
, and
Roderick Clifton-Bligh Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close

Introduction The incidence of thyroid cancer is increasing worldwide [ 1 ]. In Australia, thyroid cancer is increasing more than any other malignancy, with incidence rising from 2.7 to 13 per 100,000 persons between 1982 and 2019 [ 2 , 3

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000516358
Volume/Issue:
Volume 10: Issue 5
Free access
Niko W. de Jong Dutch Association of Graves’ Patients

Search for other papers by Niko W. de Jong in
Google Scholar
PubMed Close
and
G.M. Baljet Royal Dutch Pharmacists Association (KNMP), Amersfoort, The Netherlands

Search for other papers by G.M. Baljet in
Google Scholar
PubMed Close

population is changing with a strong increase of the ageing population. As the incidence of Hashimoto’s hypothyroidism increases with advancing age, a greying population will increase the use of thyroid hormones. Nevertheless, this cannot be the whole

Article Type:
Letter
DOI:
https://doi.org/10.1159/000339449
Volume/Issue:
Volume 1: Issue 2
Free access